- $594.92m
- $591.86m
- $126.08m
U.S. STOCKS ON THE MOVE-US Foods, BridgeBio, CureVac
U.S. STOCKS ON THE MOVE-Vera Therapeutics, FedEx, US Foods
U.S. STOCKS ON THE MOVE-Innovative Eyewear, BranchOut Food, Estee Lauder
Surmodics up on FDA's nod for vascular disease device
Brief: Surmodics Receives FDA Approval For The SurVeil Drug-Coated Balloon
Brief: Surmodics Receives FDA 510(K) Clearance For Pounce™ Lp Thrombectomy System
Surmodics gains after Needham upgrades stock rating to 'buy'
Brief: Surmodics Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Surmodics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Surmodics Q2 Loss Per Share USD 0.55
Brief: Surmodics Reports Second Quarter Of Fiscal Year 2023 Financial Results
Surmodics Inc expected to post a loss of 48 cents a share - Earnings Preview
Brief: Surmodics Enrolled First Patient In Study Using Pounce Thrombectomy System
Brief: Surmodics Announces Successful First Patient Use Of Sublime Radial Access Microcatheter
Brief: Surmodics Provides Regulatory Update On Its Strategy To Submit An Amended Premarket Approval Application For The Surveil™ Drug-Coated Balloon
Surmodics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Surmodics Reports Q1 Of Fiscal Year 2023 Financial Results
Surmodics Inc expected to post a loss of 66 cents a share - Earnings Preview
Brief: Surmodics To Reduce Company's Workforce By Approximately 13%